Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4A11 | Q02928 | 4/20 | 0.51 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.51 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.49 |
| ▸ | MDH1 | P40925 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | PLK1 | P53350 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | XDH | P47989 | 1/20 | 0.46 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16247137 | 0.96 | CYP4A11 (0.51) | CYP4A11CYP4F2GPR84MDH1CA12 | |
| SCHEMBL16950976 | 0.93 | PRKCA (0.51) | CYP4A11CYP4F2GPR84MDH1CA12 | |
| SCHEMBL25340179 | 0.93 | GPR84 (0.54) | CYP4A11CYP4F2GPR84MDH1 | |
| SCHEMBL16955938 | 0.90 | CYP4A11 (0.47) | CYP4A11CYP4F2GPR84MDH1CA12 | |
| SCHEMBL15963129 | 0.89 | CYP4A11 (0.53) | CYP4A11CYP4F2GPR84MDH1 | |
| SCHEMBL16950973 | 0.86 | CYP4A11 (0.43) | CYP4A11CYP4F2GPR84MDH1CA12 | |
| SCHEMBL16956798 | 0.85 | MDH1 (0.43) | CYP4A11CYP4F2GPR84MDH1CA12 | |
| SCHEMBL16956800 | 0.85 | THRB (0.43) | CYP4A11CYP4F2MDH1CA12CA1 | |
| SCHEMBL17367304 | 0.84 | CYP4A11 (0.48) | CYP4A11CYP4F2GPR84MDH1 | |
| SCHEMBL7110194 | 0.84 | CYP4A11 (0.48) | CYP4A11CYP4F2GPR84MDH1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9793499-B2 | Organic iridium complex for organic electroluminescent element | TANAKA KIKINZOKU KOGYO K.K. (JP) | 2017-10-17 | — | — | US | disclosed |
| US-20170237021-A1 | ORGANIC IRIDIUM COMPLEX FOR ORGANIC ELECTROLUMINESCENT ELEMENTS | TANAKA KIKINZOKU KOGYO K.K. (JP) | 2017-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170237021-A1 | ORGANIC IRIDIUM COMPLEX FOR ORGANIC ELECTROLUMINESCENT ELEMENTS | L1CAM, ETFA, TTI2 | CYP4A11 4292/4885CYP4F2 2127/4885GPR84 3487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.